Off-the-Shelf cell therapy takes on tough leukemia
Disease control
Not yet recruiting
This early-stage study tests a new type of CAR-T cell therapy for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses donor cells engineered to target a protein called CLL1 found on most AML cells, and is designed …
Phase: PHASE1 • Sponsor: Mingfeng Zhao • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC